• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

R.A.C.E. To Diagnose ALS/MND

A Call to Action to Refer Early Across Diverse Healthcare Settings

 

    This project was initiated and funded by My Name’5 Doddie Foundation.   

Learning Objectives

  • Recognize the early signs and symptoms of ALS/MND across diverse healthcare settings and specialties
  • Assess clinical features and initiate appropriate investigations (if warranted) without delaying referral
  • Communicate the need for an urgent onward specialist referral to those with suspected ALS/MND
  • Expedite referrals — even in the absence of complete diagnostic confirmation — and ensure referral letters clearly communicate key clinical findings to support triage

Resources

  • Content
  • Evaluation Form
  • Invitation Live Event
  • Invitation Virtual Event
  • Participant Handout
  • Speaker Guide
  • Certificate (with speaker)
  • Certificate
  • Sign-in Sheet

Videos

Person Living with ALS/MND Sharing His Diagnostic Journey

Mr. Craig Reyenga,

Craig Reyenga, a person living with ALS/MND, shares his challenging diagnostic journey and the difficulties he faced throughout the process.

https://www.als-mnd.org/wp-content/uploads/2026/02/craig_reyenga´s_als_mnd_diagnosis_story_v1-1080p.mp4

Overcoming Therapeutic Nihilism in ALS/MND

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

Prof. Hardiman addresses the misconception that ALS/MND referrals are futile, stressing that multidisciplinary clinics significantly improve quality of life, offer access to research and emerging therapies, and provide meaningful hope for patients.

https://www.als-mnd.org/wp-content/uploads/2026/02/orla_hardiman_-_overcoming_therapeutic_nihilism_v1-720p.mp4

The Cost of Delayed Diagnosis: Personal Stories from the Faculty

Members of the faculty present cases they have encountered that highlight the real-world impact of diagnostic delays in ALS/MND.

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

https://www.als-mnd.org/wp-content/uploads/2026/02/video_orla_hardiman_-_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Ms. Marla Calder, BScOT

https://www.als-mnd.org/wp-content/uploads/2026/02/marla_calder_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Prof. Christopher J. McDermott, PhD, MD, FRCP

https://www.als-mnd.org/wp-content/uploads/2026/02/chris_mcdermott_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

Prof. Nortina Shahrizaila, DM, PhD, FRCP 

https://www.als-mnd.org/wp-content/uploads/2026/02/nortina_shahrizaila_–_the_cost_of_delayed_diagnosis__personal_stories_from_the_faculty_v1-720p.mp4

RECAP: When to Suspect ALS/MND and Refer

Prof. Nortina Shahrizaila, DM, PhD, FRCP

Prof. Shahrizaila summarizes key red flags for ALS/MND, such a progressive, painless loss of motor function or unexplained weight loss with breathing difficulty, and emphasizes the need for immediate referral when symptoms do not fit typical patterns.

https://www.als-mnd.org/wp-content/uploads/2026/02/nortina_shahrizaila_-_recap__when_to_suspect_als_mnd_and_refer_v1-720p.mp4

Avoid Diagnostic Pitfalls: Prioritize Urgent Referrals

Prof. Orla Hardiman, BSc, MB, MD, FRCPI, FTCD, MRIA

Prof. Hardiman advises non-specialists to refer suspected ALS/MND cases promptly rather than ordering exhaustive tests, noting that early referral prevents delays, reduces unnecessary costs, and ensures patients access specialized evaluation.

https://www.als-mnd.org/wp-content/uploads/2026/02/orla_hardiman_-_avoid_diagnostic_pitfalls__prioritize_urgent_referrals_v1-720p.mp4

Craig’s MRI Maze: A Journey Through Missed Opportunities and Delayed Referral

Mr. Craig Reyenga

Craig Reyenga reflects on his prolonged diagnostic process and how delays left him uncertain about how to live his life and plan for the future, wishing he had been referred to a specialist sooner.

https://www.als-mnd.org/wp-content/uploads/2026/02/craig_reyenga_-_a_journey_through_missed_opportunities_and_delayed_referral_v1-720p.mp4

Faculty Perspective: Frustration with Referral Delays

Prof. Christopher J. McDermott, PhD, MD, FRCP

Prof. McDermott discusses the frustration of receiving late referrals for ALS/MND patients, emphasizing how waiting for diagnostic certainty delays care, support, and access to clinical trials. He urges clinicians to refer early if ALS/MND is even a possibility.

https://www.als-mnd.org/wp-content/uploads/2026/02/chris_mcdermott_–_frustration_with_referral_delays_v1-720p.mp4

From Diagnostic Uncertainty to Clarity: Insights from the Voices of People Living with ALS/MND

Two people living with ALS/MND share their journey, describing the impact of not having a diagnosis and how they felt once it was confirmed.

Ms. Leanne Sklavenitis

https://www.als-mnd.org/wp-content/uploads/2026/03/ALALS2501-video-de-Leanne-v3.mp4

Mr. Bruce Virgo

https://www.als-mnd.org/wp-content/uploads/2026/03/ALALS2501-Bruce-video-v5-1.mp4

What If the Patient Asks: “Could this be ALS/MND?”

Ms. Marla Calder, BScOT

Marla Calder explains how allied health professionals should respond when patients raise concerns about serious conditions—by being honest, supportive, and ensuring prompt referral and clear documentation rather than attempting to diagnose.

https://www.als-mnd.org/wp-content/uploads/2026/02/marla_calder_–_what_if_the_patient_asks__could_this_be_als_mnd__v1-720p.mp4

 

For additional information or enquiries on booking the faculty, please email education@als-mnd.org.

Primary Sidebar

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Hollister

    Hollister
    hollister

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Jay Epstein, USA

    Jay Epstein, USA

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • David Solomon, UK

    David Solomon, UK

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Mike Cels, Canada

    Mike Cels, Canada

  • John Russo, USA

    John Russo, USA
    final3878

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Susan Anderson, USA

    Susan Anderson, USA

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Jon Newsome, USA

    Jon Newsome, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Rob Tison, USA

    Rob Tison, USA

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Jon Newsome, USA

    Jon Newsome, USA

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Ian Gale, Australia

    Ian Gale, Australia

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Bob Simonds, USA

    Bob Simonds, USA

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Ali Var, Turkey

    Ali Var, Turkey

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login